Expanded ILC2s in human infant intestines promote tissue growth
Standard
Expanded ILC2s in human infant intestines promote tissue growth. / Möller, Kimberly J; Wegner, Lucy H M; Malsy, Jakob; Baumdick, Martin E; Borggrewe, Malte; Jordan-Paiz, Ana; Jung, Johannes M; Martrus, Glòria; Kretschmer, Paul; Sagebiel, Adrian F; Schreurs, Renée R C E; Hagen, Sven H; Burmester, Gunter; Clauditz, Till S; Pals, Steven T; Boettcher, Michael; Melling, Nathaniel; Sauter, Guido; Tomuschat, Christian; Königs, Ingo; Schumacher, Udo; Altfeld, Marcus; Bernink, Jochem H; Perez, Daniel; Reinshagen, Konard; Bunders, Madeleine J.
in: MUCOSAL IMMUNOL, Jahrgang 16, Nr. 4, 08.2023, S. 408-421.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Expanded ILC2s in human infant intestines promote tissue growth
AU - Möller, Kimberly J
AU - Wegner, Lucy H M
AU - Malsy, Jakob
AU - Baumdick, Martin E
AU - Borggrewe, Malte
AU - Jordan-Paiz, Ana
AU - Jung, Johannes M
AU - Martrus, Glòria
AU - Kretschmer, Paul
AU - Sagebiel, Adrian F
AU - Schreurs, Renée R C E
AU - Hagen, Sven H
AU - Burmester, Gunter
AU - Clauditz, Till S
AU - Pals, Steven T
AU - Boettcher, Michael
AU - Melling, Nathaniel
AU - Sauter, Guido
AU - Tomuschat, Christian
AU - Königs, Ingo
AU - Schumacher, Udo
AU - Altfeld, Marcus
AU - Bernink, Jochem H
AU - Perez, Daniel
AU - Reinshagen, Konard
AU - Bunders, Madeleine J
N1 - Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2023/8
Y1 - 2023/8
N2 - Early life is characterized by extraordinary challenges, including rapid tissue growth and immune adaptation to foreign antigens after birth. During this developmental stage, infants have an increased risk of immune-mediated diseases. Here, we demonstrate that tissue-resident, interleukin (IL)-13- and IL-4-producing group 2 innate lymphoid cells (ILC2s) are enriched in human infant intestines compared to adult intestines. Organoid systems were employed to assess the role of infant intestinal ILC2s in intestinal development and showed that IL-13 and IL-4 increased epithelial cell proliferation and skewed cell differentiation toward secretory cells. IL-13 furthermore upregulated the production of mediators of type-2 immunity by infant intestinal epithelial cells, including vascular endothelial growth factor-A and IL-26, a chemoattractant for eosinophils. In line with these in vitro findings increased numbers of eosinophils were detected in vivo in infant intestines. Taken together, ILC2s are enriched in infant intestines and can support intestinal development while inducing an epithelial secretory response associated with type 2 immune-mediated diseases.
AB - Early life is characterized by extraordinary challenges, including rapid tissue growth and immune adaptation to foreign antigens after birth. During this developmental stage, infants have an increased risk of immune-mediated diseases. Here, we demonstrate that tissue-resident, interleukin (IL)-13- and IL-4-producing group 2 innate lymphoid cells (ILC2s) are enriched in human infant intestines compared to adult intestines. Organoid systems were employed to assess the role of infant intestinal ILC2s in intestinal development and showed that IL-13 and IL-4 increased epithelial cell proliferation and skewed cell differentiation toward secretory cells. IL-13 furthermore upregulated the production of mediators of type-2 immunity by infant intestinal epithelial cells, including vascular endothelial growth factor-A and IL-26, a chemoattractant for eosinophils. In line with these in vitro findings increased numbers of eosinophils were detected in vivo in infant intestines. Taken together, ILC2s are enriched in infant intestines and can support intestinal development while inducing an epithelial secretory response associated with type 2 immune-mediated diseases.
KW - Adult
KW - Humans
KW - Infant
KW - Immunity, Innate
KW - Interleukin-13
KW - Lymphocytes
KW - Vascular Endothelial Growth Factor A
KW - Interleukin-4
KW - Intestines
KW - Interleukin-33
KW - Cytokines/metabolism
U2 - 10.1016/j.mucimm.2023.04.004
DO - 10.1016/j.mucimm.2023.04.004
M3 - SCORING: Journal article
C2 - 37121384
VL - 16
SP - 408
EP - 421
JO - MUCOSAL IMMUNOL
JF - MUCOSAL IMMUNOL
SN - 1933-0219
IS - 4
ER -